Nature Biotechnology
New tech transfer models gain traction with deal flow
New tech transfer models gain traction with deal flow
Nature Biotechnology 28, 634 (2010). doi:10.1038/nbt0710-634
Author: John Hodgson
French IPO spate
Industrial biotech to boom?
Industrial biotech to boom?
Nature Biotechnology 28, 635 (2010). doi:10.1038/nbt0710-635c
Author: Daniel Grushkin
Sequencing firms vie for diagnostics market, tiptoe round patents
Sequencing firms vie for diagnostics market, tiptoe round patents
Nature Biotechnology 28, 635 (2010). doi:10.1038/nbt0710-635a
Author: Michael Eisenstein
Merck ditches biogeneric
Merck ditches biogeneric
Nature Biotechnology 28, 636 (2010). doi:10.1038/nbt0710-636a
Author: Emma Dorey
Investors fight Charles River/WuXi merger
Investors fight Charles River/WuXi merger
Nature Biotechnology 28, 636 (2010). doi:10.1038/nbt0710-636b
Author: Suzanne Elvidge
Genzyme partners TJAB
Genzyme partners TJAB
Nature Biotechnology 28, 637 (2010). doi:10.1038/nbt0710-637b
Author: Jennifer Rohn
China's heparin billionaires
China's heparin billionaires
Nature Biotechnology 28, 637 (2010). doi:10.1038/nbt0710-637c
Author: Hepeng Jia
Microcap public biotechs access new pool of VC funding
Microcap public biotechs access new pool of VC funding
Nature Biotechnology 28, 637 (2010). doi:10.1038/nbt0710-637a
Author: Peter Mitchell
Italian GM rebels
Italian GM rebels
Nature Biotechnology 28, 638 (2010). doi:10.1038/nbt0710-638
Author: Anna Meldolesi
Newsmaker: Agios Pharmaceuticals
Newsmaker: Agios Pharmaceuticals
Nature Biotechnology 28, 639 (2010). doi:10.1038/nbt0710-639
Author: Joe Alper & Lisa Melton
Agios has brought cancer metabolism into vogue and is making hay from tumor cells' well-known hunger for glucose.
Drug pipeline: Q210
Sunshine on conflicts
Sunshine on conflicts
Nature Biotechnology 28, 641 (2010). doi:10.1038/nbt0710-641
Author: Virginia Hughes
US drug companies are preparing for new draconian provisions for reporting on financial relationships with academia. Will efforts to increase transparency prove burdensome to researchers and the industry? Virginia Hughes investigates.
PeptideClassifier for protein inference and targeted quantitative proteomics
PeptideClassifier for protein inference and targeted quantitative proteomics
Nature Biotechnology 28, 647 (2010). doi:10.1038/nbt0710-647
Authors: Ermir Qeli & Christian H Ahrens
Minimum information about a protein affinity reagent (MIAPAR)
Minimum information about a protein affinity reagent (MIAPAR)
Nature Biotechnology 28, 650 (2010). doi:10.1038/nbt0710-650
Authors: Julie Bourbeillon, Sandra Orchard, Itai Benhar, Carl Borrebaeck, Antoine de Daruvar, Stefan Dübel, Ronald Frank, Frank Gibson, David Gloriam, Niall Haslam, Tara Hiltker, Ian Humphrey-Smith, Michael Hust, David Juncker, Manfred Koegl, Zoltàn Konthur, Bernhard Korn, Sylvia Krobitsch, Serge Muyldermans, Per-Åke Nygren, Sandrine Palcy, Bojan Polic, Henry Rodriguez, Alan Sawyer, Martin Schlapshy, Michael Snyder, Oda Stoevesandt, Michael J Taussig, Markus Templin, Matthias Uhlen, Silvere van der Maarel, Christer Wingren, Henning Hermjakob & David Sherman
Guidelines for reporting the use of column chromatography in proteomics
Guidelines for reporting the use of column chromatography in proteomics
Nature Biotechnology 28, 654 (2010). doi:10.1038/nbt0710-654a
Authors: Andrew R Jones, Kathleen Carroll, David Knight, Kirsty MacLellan, Paula J Domann, Cristina Legido-Quigley, Lihua Huang, Lance Smallshaw, Hamid Mirzaei, James Shofstahl & Norman W Paton
Guidelines for reporting the use of capillary electrophoresis in proteomics
Guidelines for reporting the use of capillary electrophoresis in proteomics
Nature Biotechnology 28, 654 (2010). doi:10.1038/nbt0710-654b
Authors: Paula J Domann, Satoko Akashi, Coral Barbas, Lihua Huang, Wendy Lau, Cristina Legido-Quigley, Stephen McClean, Christian Neusüß, David Perrett, Milena Quaglia, Erdmann Rapp, Lance Smallshaw, Norman W Smith, W Franklin Smyth & Chris F Taylor
Guidelines for reporting the use of gel image informatics in proteomics
Guidelines for reporting the use of gel image informatics in proteomics
Nature Biotechnology 28, 655 (2010). doi:10.1038/nbt0710-655
Authors: Christine Hoogland, Martin O'Gorman, Philippe Bogard, Frank Gibson, Matthias Berth, Simon J Cockell, Andreas Ekefjärd, Ola Forsstrom-Olsson, Anna Kapferer, Mattias Nilsson, Salvador Martínez-Bartolomé, Juan Pablo Albar, Sira Echevarría-Zomeño, Montserrat Martínez-Gomariz, Johann Joets, Pierre-Alain Binz, Chris F Taylor, Andrew Dowsey & Andrew R Jones
The 20-year environmental safety record of GM trees
The 20-year environmental safety record of GM trees
Nature Biotechnology 28, 656 (2010). doi:10.1038/nbt0710-656
Authors: Christian Walter, Matthias Fladung & Wout Boerjan
The pros and cons of peptide-centric proteomics
The pros and cons of peptide-centric proteomics
Nature Biotechnology 28, 659 (2010). doi:10.1038/nbt0710-659
Authors: Mark W Duncan, Ruedi Aebersold & Richard M Caprioli
Recommendations on how best to exploit the strengths of peptide-centric proteomics and avoid its pitfalls.
